Abbott says it reached agreement with DexCom to settle their outstanding patent disputes related to continuous glucose monitoring products.
- No financial payments associated with the settlement by either company
- Settlement details are confidential
- NOTE: Nov. 14,
Abbott Gets Damages Trial as Judge Adds to DexCom’s Patent Woes
To view the source of this information, click
To contact the reporter on this story:
To contact the editor responsible for this story:
© 2024 Bloomberg L.P. All rights reserved. Used with permission.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.